Harvard Bioscience, Inc. (FRA:HBI0)

Market Cap	18.68M -27.3%
Revenue (ttm)	73.71M -8.1%
Net Income	-48.29M
EPS	-10.90
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	4.080
Previous Close	4.240
Day's Range	4.080 - 4.080
52-Week Range	2.140 - 8.400
Beta	n/a
RSI	38.58
Earnings Date	May 4, 2026

About Harvard Bioscience

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including d...

• Industry: Laboratory Analytical Instruments
• Founded: 1901
• Employees: 339
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: HBI0

Financial Performance

In 2025, Harvard Bioscience's revenue was $86.55 million, a decrease of -8.06% compared to the previous year's $94.14 million. Losses were -$56.70 million, 357.1% more than in 2024.

Financial numbers in USD